Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - inactivated newcastle disease virus ; paramyxovirus 3, inactivated ; inactivated turkey rhinotracheitis virus - emulsion for injection - . - turkey paramyxovirus + turkey rhinotracheitis virus - turkeys - immunological - inactivated vaccine

United States - English - NLM (National Library of Medicine)

key therapeutics - methamphetamine hydrochloride (unii: 997f43z9cv) (methamphetamine - unii:44ral3456c) - attention deficit disorder with hyperactivity: desoxyn tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children over 6 years of age with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. in patients known to be hypersensitive to amphetamine, or other components of desoxyn. hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine p

United States - English - NLM (National Library of Medicine)

key therapeutics, llc - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen 125 mg in 5 ml - carefully consider the potential benefits and risks of naproxen suspension and other treatment options before deciding to use naproxen suspension. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings; gastrointestinal bleeding, ulceration, and perforation) . naproxen suspension is indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile rheumatoid arthritis naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient's weight. naproxen suspension is also indicated: - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout -

United States - English - NLM (National Library of Medicine)

key therapeutics - methocarbamol (unii: 125od7737x) (methocarbamol - unii:125od7737x) - methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. the mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. methocarbamol does not directly relax tense skeletal muscles in man. methocarbamol is contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.

United States - English - NLM (National Library of Medicine)

key therapeutics - methocarbamol (unii: 125od7737x) (methocarbamol - unii:125od7737x) - methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. the mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. methocarbamol does not directly relax tense skeletal muscles in man. methocarbamol is contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.

United States - English - NLM (National Library of Medicine)

key therapeutics - imipramine hydrochloride (unii: bke5q1j60u) (imipramine - unii:ogg85sx4e4) - depression -for the relief of symptoms of depression. endogenous depression is more likely to be al l eviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. childhood enuresis -may be useful as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older, after possible organic causes have been excluded by appropriate tests. in patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. the effectiveness of treatment may decrease with continued drug administration. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute imipramine hydrochloride in patients receiving a monoamine oxidase inhibitor, as long a

Ireland - English - HPRA (Health Products Regulatory Authority)

merial animal health limited - paramyxovirus 3, inactivated, inactivated newcastle disease virus, inactivated turkey rhinotracheitis virus - emulsion for injection - 8-9.2 log10, 9-10.3 log10, 5-8 log10 eid50/ccid50 - turkey paramyxovirus + turkey rhinotracheitis virus - turkeys - immunological - inactivated vaccine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lofarma - turkey meat allergen extract - solution for skin-prick test

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

inmunotek - turkey meat allergen extract - solution for skin-prick test

Australia - English - Department of Health (Therapeutic Goods Administration)

key-sun laboratories pty ltd - 4-methylbenzylidene camphor,butyl methoxydibenzoylmethane,octocrylene,zinc oxide -